Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01422473 · ClinicalTrials.gov registry record · NA

Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques

A NA study, sponsored by Swedish Medical Center.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT01422473: Clinical Trial NA study, sponsored by Swedish Medical Center.

NCT01422473 is a NA study that was terminated before completion, run by Swedish Medical Center. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01422473, a NA study, was terminated before completion, sponsored by Swedish Medical Center.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to examine the advantages and disadvantages of using the EnSeal device in hemorrhoid surgery as compared to traditional hemorrhoid surgery techniques. It is hypothesized that the use of the Enseal device will demonstrate an improvement a patient's overall experience through less postoperative bleeding and pain, decreased time for wound healing, and a faster return to work.

Primary Outcome

Patients will be assess for postoperative complications including but not limited to: bleeding, urinary retention, fecal impaction, hospital re-admission and pain.

Interventions

  • DEVICE EnSeal Trio Tissue Sealing Device

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2011-08
Est. Completion 2013-01
Phase NA
Swedish Medical Center

30 total trials

Why NCT01422473 stopped before completion

NCT01422473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which EnSeal Trio Tissue Sealing Device is the first listed.

NCT01422473 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01422473 about?

NCT01422473 is a clinical study titled "Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques". The purpose of this study is to examine the advantages and disadvantages of using the EnSeal device in hemorrhoid surgery as compared to traditional hemorrhoid surgery techniques. It is hypothesized that the use of the Enseal device will demonstrate an improvement a patient's overall experience thr...

What is the current status of trial NCT01422473?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2011-08. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01422473?

The interventions under investigation include: EnSeal Trio Tissue Sealing Device (DEVICE).

Who is sponsoring clinical trial NCT01422473?

This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01422473's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01422473, the US trial registry maintained by the National Library of Medicine. NCT01422473 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.